A 49-year-old man with metastatic rectal cancer to the liver saw disease progression despite multiple treatments. After starting anti-PD-1 immunotherapy, his tumors shrank dramatically—showing promising results after other therapies failed.
Turning Point in the Fight Against Liver Metastases Read More »
A 62-year-old woman with Lynch syndrome and advanced rectal cancer faced multiple tumors and a poor prognosis. Through targeted chemotherapy, surgery, and immunotherapy, she is now disease-free after nearly two years
Liver metastases represent a significant challenge in colorectal cancer (CRC) management, affecting approximately 20% of patients at initial diagnosis (synchronous) and up to 60% during disease progression (metachronous). This report synthesizes current treatment recommendations from major oncology organizations including ASCO, NCCN, and ESMO, highlighting evidence-based approaches based on disease presentation and therapeutic goals.
Treatment Options for Liver Metastases in Colorectal Cancer: Guidelines Summary Read More »
A 44-year-old man was diagnosed with rectal cancer with liver metastases after a routine checkup revealed blood in his stool. Through a combination of surgery and chemotherapy, he achieved a complete pathological response and remains cancer-free five years later.
Beating Stage IV Rectal Cancer with Surgery and Chemotherapy Read More »
Recent breakthrough research has revealed promising news for colorectal cancer survivors with specific genetic mutations, suggesting that a simple daily aspirin could significantly reduce cancer recurrence. This development represents a potential paradigm shift in post-treatment care for a substantial subset of colorectal cancer patients, offering an inexpensive and accessible intervention with remarkable efficacy. Understanding Aspirin’s
Preventing Colorectal Cancer Recurrence: Latest Findings on Low-Dose Aspirin Therapy Read More »
A 59-year-old female with a history of stage IV rectal cancer presented with a rare isolated splenic metastasis discovered five years post-surgery. Laparoscopic splenectomy confirmed metastatic colorectal adenocarcinoma, emphasizing the importance of ongoing surveillance and individualized treatment strategies.
Overcome Rectal Cancer Recurrence with Timely Intervention Read More »
A 68-year-old man presented with rectal bleeding and stool narrowing, later diagnosed with distal rectal cancer. After preoperative chemoradiotherapy and abdominoperineal resection, he achieved a complete pathological response, underscoring the impact of a strategic, multidisciplinary treatment
Triumph Over Distal Rectal Cancer: A Complete Pathological Response Read More »
A 51-year-old woman diagnosed with stage IV rectal cancer in 2015 underwent seven surgeries and multiple treatments over seven years. Through multidisciplinary interventions, she achieved remarkable disease control and sustained a high quality of life
A 7-year Journey with Stage IV Rectal Cancer Read More »
A 54-year-old female patient was admitted to the outpatient department of Abdominal Radiotherapy of our hospital due to intermittent stool bleeding in April 2021. Through a multidisciplinary approach that combined immunotherapy, chemotherapy, and targeted radiotherapy, this patient overcame rectal squamous cell carcinoma and ultimately achieved No Evidence of Disease (NED).
Triumph Over Rare Rectal Squamous Cell Carcinoma Read More »
Discover how Ida overcame a terminal Stage IV colorectal cancer diagnosis through surgery, clinical trials, and unwavering hope—emerging cancer-free and ready to explore the world.
From “Terminal” to Cancer-Free: A Remarkable Stage IV Rectal Cancer Journey Read More »
